Las Vegas, NV -- (SBWIRE) -- 10/25/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: MELA Sciences Inc (NASDAQ:MELA), Vical Incorporated (NASDAQ: VICL), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), Golden Star Resources Ltd. (USA) (NYSEMKT: GSS)
MELA Sciences Inc (NASDAQ:MELA) managed to keep its gain at 25.81% on above-normal volume of 2.55M shares. The stock settled at $0.990 after floating in a range of $0.75 to $0.99. Its latest price has reached market capitalization of $42.68 million. Its 52-week range has been $0.65 to $3.19. MELA Sciences, Inc. is a medical device company focused on the commercialization of its product, MelaFind, and the further design and development of MelaFind and its technology. MelaFind is a non-invasive, point-of-care (in the doctor's office) instrument to aid in the detection of melanoma. MelaFind, features a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions.
For How Long MELA will fight for Profitability? Read This Trend Analysis report
Vical Incorporated (NASDAQ: VICL) traded down on a volume of 2.50 million, higher than its standard daily volume. Shares have dropped-0.67% to $1.48. Over the last twelve months, the stock has lost-59.34% and faced a worst price of $1.17. Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Has VICL Found The Bottom And Ready To Gain Momentum? Find Out Here
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) settled -3.98% lower at $1.93 on below -normal volume of 2.40M shares during the last trading day. The stock has its 12-month high at $3.65 and 52-week low price was $0.37. It traded in a range of $1.83 to $2.01 during the last trading day. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.
Will CPRX Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Golden Star Resources Ltd. (USA) (NYSEMKT: GSS) was up on low volume, trading at a volume of 2.39M shares versus its average daily volume of 3.78 million shares. At $0.508, the stock has attained market capitalization of $131.60 million. Golden Star Resources Ltd, (Golden Star) is an international gold mining and exploration company producing gold in Ghana, West Africa.
Will GSS Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)